CAIRO– In the presence of Prime Minister Moustafa Madbouli, an agreement was signed Wednesday between the Holding Company for Biological Products and Vaccines (VACSERA) and the UAE-based Exeed Industries and Scope Investment to establish, manage and operate a factory to manufacture Re-Use Prevention (RUP) syringes.
Putting their signatures to the deal were Dr Heba Waly, the executive managing director of VACSERA, Farid al Belbeisi, CEO of Scope Investment and legal representative of Exeed Industries Saeid Mohamed Radwan.
Attending the inking ceremony was Health Minister Dr Khaled Abdel Ghaffar, who believes the agreement would help benefit from one of the assets owned by VACSERA at the company’s industrial complex in the 6th of October City.
The plant should be established over a total area of 6,400 square meters and should produce about 150 to 240 million units annually, Abdel Ghaffar said
He expected the project to cost some 10 million dollars.
Discussion about this post